Aaron L Olsen
Overview
Explore the profile of Aaron L Olsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Odum A, Willis-Moore M, Callister K, Haynes J, Frye C, Scribner L, et al.
J Exp Anal Behav
. 2025 Mar;
PMID: 40085141
Tobacco use is the leading cause of death globally and in the United States. After decades of decline, driven by decreases in combusted tobacco use, nicotine product use has increased...
2.
Odum A, Willis-Moore M, Callister K, Haynes J, Frye C, Scribner L, et al.
bioRxiv
. 2025 Jan;
PMID: 39763771
Tobacco use is the leading cause of death globally and in the U.S. After decades of decline, driven by decreases in combusted tobacco use, nicotine product use has increased due...
3.
ONeill D, Sato E, Thorne T, Mau M, Klonoski J, Olsen A, et al.
J Orthop Surg Res
. 2024 Oct;
19(1):622.
PMID: 39367457
Background: Most existing animal models of acute compartment syndrome (ACS) rely on exogenous manipulation of intra-compartmental pressures to model ACS. The purpose of the current study was to evaluate the...
4.
Freeman S, Catrow J, Cox J, Turano A, Rich M, Ihrig H, et al.
Comp Med
. 2024 Mar;
74(1):3-11.
PMID: 38532262
L-368,899 is a selective small-molecule oxytocin receptor (OXTR) antagonist originally developed in the 1990s to prevent preterm labor. Although its utility for that purpose was limited, L-368,899 is now one...
5.
Regouski M, Galenko O, Doleac J, Olsen A, Jacobs V, Liechty D, et al.
Circ Arrhythm Electrophysiol
. 2019 Nov;
12(11):e007499.
PMID: 31707807
Background: There is increasing evidence that endurance exercise is associated with increased risk of atrial fibrillation (AF). However, it is unknown if the relationship between endurance exercise and AF is...
6.
Olsen A, Long M
J Biomed Mater Res A
. 2018 Sep;
106(12):3143-3151.
PMID: 30194709
Thrombogenicity testing is a key component in the development of medical devices intended for contact with blood. The Chandler loop system has previously been used as an in vitro thrombogenicity...
7.
Yun S, Song B, Frank J, Julander J, Olsen A, Polejaeva I, et al.
Viruses
. 2018 Aug;
10(8).
PMID: 30103523
Zika virus (ZIKV) causes no-to-mild symptoms or severe neurological disorders. To investigate the importance of viral and host genetic variations in determining ZIKV infection outcomes, we created three full-length infectious...
8.
Hill R, Mason H, Yeip G, Merchant S, Olsen A, Stott R, et al.
Arthritis
. 2017 Mar;
2017:7481619.
PMID: 28348888
Large animal models of osteoarthritis are a necessary testing ground for FDA approval of human medicine applications. Sheep models have advantages over other available large animals, but development and progression...
9.
Polejaeva I, Ranjan R, Davies C, Regouski M, Hall J, Olsen A, et al.
J Cardiovasc Electrophysiol
. 2016 Jul;
27(10):1220-1229.
PMID: 27447370
Introduction: Large animal models of progressive atrial fibrosis would provide an attractive platform to study relationship between structural and electrical remodeling in atrial fibrillation (AF). Here we established a new...
10.